Search Results - M. A Dimopoulos

Refine Results
  1. 1

    Colon Adenoma Implicating Myasthenia Gravis: A Case Report of a Patient with Postcolectomy Complications by Y. Papachatzakis, E. Tseliou, I. Tatouli, I. Dialoupi, F. Michas, E. Papadopoulou, D. Kousouris, S. Kontogiannis, M. A. Dimopoulos

    Published in Case Reports in Neurological Medicine (2016-01-01)
    Get full text
    Article


  2. 2

    PB1983: TRIAL-IN-PROGRESS: PHASE II STUDY OF PHE885, A B-CELL MATURATION ANTIGEN-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN ADULTS WITH RELAPSED AND/OR REFRACTORY MULTIP... by N. Munshi, A. Spencer, M. S. Raab, A. Masood, M. Martinez-Prieto, J. Chu, S. Iida, S. Lonial, M. A. Dimopoulos

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    S178: SAFETY AND EFFICACY OF BELANTAMAB MAFODOTIN IN COMBINATION WITH RD IN NEWLY DIAGNOSED, TRANSPLANT INELIGIBLE MULTIPLE MYELOMA PATIENTS: A PHASE 1/2 STUDY BY THE HELLENIC SOCI... by E. Terpos, M. Gavriatopoulou, I. Ntanasis-Stathopoulos, P. Malandrakis, D. Fotiou, N. Kanellias, S. Gkolfinopoulos, K. Manousou, E. Kastritis, M.-A. Dimopoulos

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  4. 4

    DP122 | ELRANATAMAB IN COMBINATION WITH DARATUMUMAB AND LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA NOT ELIGIBLE FOR TRANSPLANT: INITIAL RESULTS FROM MAGNETISMM-... by C. Liberatore, H. Quach, L. . Pour, S. Grosicki, H. Sia, J. Minarik, J Byun, C. Touzeau, S. Sullivan, E. Leip, E. Shaikh, A. Viqueira, M.A. Dimopoulos

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  5. 5

    P915: EFFICACY AND SAFETY OF DARATUMUMAB MONOTHERAPY IN NEWLY DIAGNOSED PATIENTS WITH STAGE 3B LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK by E. Kastritis, M. C. Minnema, M. A. Dimopoulos, G. Merlini, F. Theodorakakou, D. Fotiou, A. Huart, K. Belhadj, S. Gkolfinopoulos, K. Manousou, P. Sonneveld, G. Palladini

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  6. 6

    P914: EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK by E. Kastritis, G. Palladini, M. A. Dimopoulos, A. Jaccard, G. Merlini, F. Theodorakakou, D. Fotiou, M. C. Minnema, A. Wechalekar, S. Gkolfinopoulos, K. Manousou, P. Sonneveld, S. Schönland

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  7. 7

    Axitinib as a third or further line of treatment in renal cancer: a single institution experience by G. Tsironis, M. Liontos, A. Kyriazoglou, K. Koutsoukos, A. Tsiara, M. Kaparelou, R. Zakopoulou, A. Cohen, E. Skafida, S. Fontara, F. Zagouri, A. Bamias, M. A. Dimopoulos

    Published in BMC Urology (2020-06-01)
    Get full text
    Article


  8. 8

    B08: A THIRD BNT162B2 DOSE INDUCES ANTIBODY RESPONSES AGAINST SARS-COV-2 EVEN IN PREVIOUSLY NON-RESPONDERS WITH MULTIPLE MYELOMA by E Terpos, M Gavriatopoulou, I Ntanasis-Stathopoulos, A Briasoulis, S Gumeni, P Malandrakis, E-D Papanagnou, M Migkou, N Kanellias, E Kastritis, I P Trougakos, M A Dimopoulos

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  9. 9

    P1507: CLINICAL PROFILE OF COVID-19 INFECTION AND IMMUNE RESPONSE AFTER 3AND6 MONTH VACCINATION AGAINST SARS-COV-2 IN ADULT PATIENTS WITH TRANSFUSION-DEPENDENT THALASSAEMIA-THE EXP... by P. Delaporta, E. Terpos, E. E. Solomou, S. Gumeni, M.-I. Chatzielefteriou, K. Toutoudaki, D. Kyriakopoulou, N. Ioakeimidou, I. Ntanasis-Stathopoulos, I. Papassotiriou, I. P. Trougakos, M. A. Dimopoulos, A. Kattamis

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  10. 10

    P54 ORAL ANTIVIRALS RITONAVIR-NIRMATRELVIR AND MOLNUPIRAVIR ARE HIGHLY EFFECTIVE IN PATIENTS WITH MULTIPLE MYELOMA AND COVID-19; A SINGLE-CENTER, PROSPECTIVE STUDY by V. Spiliopoulou, I. Ntanasis-Stathopoulos, P. Malandrakis, M. Gavriatopoulou, F. Theodorakakou, D. Fotiou, R. E. Syrigou, M. Migkou, M. Roussou, E. Eleutherakis-Papaiakovou, E. Kastritis, M. A Dimopoulos, E. Terpos

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  11. 11

    P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA by I. Ntanasis-Stathopoulos, M. Gavriatopoulou, E. Eleutherakis-Papaiakovou, P. Malandrakis, V. Spiliopoulou, R.E. Syrigou, F. Theodorakakou, D. Fotiou, M. Migkou, M. Roussou, E. Kastritis, M.A. Dimopoulos, E. Terpos

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  12. 12

    P14 OCULAR TOXICITY IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH BELANTAMAB MAFODOTIN, LENALIDOMIDE AND DEXAMETHASONE IN A PHASE 1/2 TRIAL by I. Ntanasis-Stathopoulos, M. Gavriatopoulou, P. Malandrakis, D. Fotiou, N. Kanellias, M. Migkou, F. Theodorakakou, V. Spiliopoulou, R. Syrigou, E. Eleutherakis-Papaiakovou, S. Gkolfinopoulos, K. Manousou, E. Kastritis, M.A. Dimopoulos, E. Terpos

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  13. 13

    PB2035: CAMMA 3: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS, AND ACTIVITY OF SUBCUTANEOUS CEVOSTAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY M... by S. Delimpasi, H. Quach, M. Cavo, P. J. Ho, C. H.-S. Lee, A. Santoro, R. Schots, P. Vlummens, D. H. Yoon, S.-S. Yoon, C. D. Santos, D. Samineni, J. Huang, K. Wehrman, U. Patil, S. Sheikh, M. A. Dimopoulos

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  14. 14

    P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAP... by A. Spencer, P. Moreau, M.-V. Mateos, H. Goldschmidt, K. Suzuki, M.-D. Levin, P. Sonneveld, S.-S. Yoon, S. Z. Usmani, K. Weisel, D. Reece, T. Ahmadi, H. Pei, W. Garvin Mayo, X. Gai, J. Carey, R. Carson, M. A. Dimopoulos

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  15. 15

    P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL by T. Thomopoulos, A. Bouchla, A. Antoniadou, E. Terpos, M. Politou, K. Stamoulis, E. Koromboki, S. Papageorgiou, A. Kotanidou, I. Kalomenidis, E. Jahaj, S. Grigoropoulou, M. Pagoni, E. Grouzi, G. Poulakou, I. Trontzas, S. Labropoulou, A. Mentis, A. Bamias, S. Tsiodras, M.-A. Dimopoulos, V. Pappa

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  16. 16

    B06 HIGH LEVELS OF CIRCULATING PLASMA CELLS AT DIAGNOSIS ARE PREDICTIVE FOR WORSE PROGNOSIS IN BOTH TRANSPLANT-ELIGIBLE AND -INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA by P. Malandrakis, I. Ntanasis-Stathopoulos, I.V. Kostopoulos, P. Roussakis, E. Eleutherakis-Papaiakovou, C. Panteli, N. Angelis, V. Spiliopoulou, N. Orologas-Stavrou, F. Theodorakakou, D. Fotiou, M. Migkou, M. Gavriatopoulou, E. Kastritis, O.E. Tsitsilonis, M.A. Dimopoulos, E. Terpos

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  17. 17

    C003 | MODELING LONG-TERM PROGRESSION-FREE SURVIVAL IN TRANSPLANT-ELIGIBLE AND TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB, BORTEZOMIB, LENALIDO... by F. Gay, P. Sonneveld, S. Zweegman, T. Facon, V. Hungria, N. J. Bahlis, P. Moreau, H. Einsele, M. Boccadoro, F. Borgsten, A. Lam, M. Nobrega, V. Kovacs, J. Wang, M. Rowe, A. Sitthi-Amorn, R. Carson, M.A. Dimopoulos, P. Rodríguez-Otero, S.Z. Usmani

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  18. 18

    C002 | SUBCUTANEOUS DARATUMUMAB + BORTEZOMIB/LENALIDOMIDE/DEXAMETHASONE WITH DARA + LENALIDOMIDE MAINTENANCE IN TRANSPLANT-ELIGIBLE PATIENTS WITH NDMM: ANALYSIS OF SUSTAINED MINIMA... by E. Antonioli, P. Moreau, P. Sonneveld, H. Einsele, H. Quach, P. Joy Ho, M. Beksac, C. Hulin, X. Leleu, S. Mangiacavalli, A. Perrot, M. Cavo, A. Belotti, A. Broijl, H. Pei, A. Sitthi-Amorn, R. L. Carson, P. Rodríguez-Otero, M.A. Dimopoulos, M. Boccadoro

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  19. 19

    P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENST... by M.-A. Dimopoulos, K. Amaador, M. C. Minnema, K. Nasserinejad, M. Kap, E. Kastritis, M. Gavriatopoulou, W. Kraan, M. E. D. Chamuleau, D. Deeren, L. Tick, J. K. Doorduijn, F. Offner, L. H. Böhmer, R. D. Liu, S. T. Pals, J. M. Vos, M. J. Kersten

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  20. 20

    DP111 | POSITRON EMISSION TOMOGRAPHY WITH COMPUTED TOMOGRAPHY AND MINIMAL RESIDUAL DISEASE FOR EFFICACY ASSESSMENT IN TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MYELOMA PATIENTS: IMROZ... by E. Zamagni, T. Facon, M.A. Dimopoulos, X. Leleu, M. Beksac, L. Pour, R. Hajek, Z. Liu, J. Minarik, P. Moreau, J. Romejko-Jarosinska, I. Spicka, T.G. Martin, L. Qiu, C. Sachpekidis, E. Kodas, H. Van De Velde, L. Zhao, R. Orlowski, H. Goldschmidt

    Published in Haematologica (2025-09-01)
    Get full text
    Article


Search Tools: